secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001171843-23-001550
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp. Q4 revenue up 26% to $27.8M; net income $547K vs loss $360K; guides 2023 revenue $123M-$128M
--------------------------------------------------------------------------------

- Q4 revenue $27.8M (+26% YoY); system-wide comp sales +8%; total clinics 838 at year-end.
- Q4 net income $547K ($0.04 diluted EPS) vs net loss $360K ($0.02 loss) YoY; Adjusted EBITDA $4.0M vs $2.1M.
- Full-year 2022 revenue $101.9M (+26%); net income $1.2M ($0.08 EPS) vs $6.6M ($0.44 EPS) in 2021.
- 2023 guidance: revenue $123M-$128M, Adjusted EBITDA $12.5M-$14.0M; franchised clinic openings 100-120, company greenfields 8-12.
- Acquired 16 previously franchised clinics in 2022; cash balance $9.7M at year-end vs $19.5M in 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323001550/0001171843-23-001550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323001550/f8k_030923.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-001550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer